ArticleEmerging microbes & infections2025

Incidence and determinants of achieving HBsAg <100 IU/mL in HBeAg-negative CHB patients with nucleos(t)ide analogue treatment.

Jian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.